Chemomab Therapeutics
NASDAQ: CMMB
$2.09
+0.18
(+9.42%)
as on
Chemomab Therapeutics Stock Performance
as on August 20, 2026 at 2:16 pm IST
Day's Low
Day's High
$1.88$2.10
10.05%
Downside
0.48%
Upside
52 Week's Low
52 Week's High
$1.35$4.1235.41%
Downside
97.13%
Upside
Chemomab Therapeutics share price movements today
- Previous Close
- $1.91
- Open
- $1.96
- Volume
- 461.4K
- Market Cap
- $14.0M
- Day's Low - High
- $1.88 - $2.10
- 52 Week Low - High
- $1.35 - $4.12
Chemomab Therapeutics Historical Returns
- 1 Month Return
- + 22.44 %
- 3 Month Return
- + 15.06 %
- 1 Year Return
- -48.66 %
- 3 Year Return
- -54.52 %
- 5 Year Return
- -96.4 %
Chemomab Therapeutics Stock Fundamentals & Key Indicators
Check Chemomab Therapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$14.0M
EPS (TTM)
-0.02
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
0PEG Ratio
0EBITDA
-7.9M
Revenue (TTM)
-
Profit Margin
0.00%
Return On Equity TTM
-70.61%
Chemomab Therapeutics vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Chemomab Therapeutics with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % | Dividend Yield % |
|---|---|---|---|---|---|---|
| BUY | $14.0M | -96.4% | NA | 0.00% | NA | |
| BUY | $43.7B | 669.3% | NA | 0.00% | NA | |
| BUY | $128.2B | 154.86% | 29.82 | 86.04% | NA | |
| BUY | $82.7B | 24.1% | 19.24 | 84.86% | 0.44999999999999996% |
Stock Returns calculator for Chemomab Therapeutics Stock including INR - Dollar returns
The Chemomab Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Investment Value
₹1,00,000
Chemomab Therapeutics investment value today
Current value as on today
₹61,779
Returns
Returns from Chemomab Therapeutics Stock
Dollar Impact
₹5,596 (+5.6%)
Analyst Recommendation on Chemomab Therapeutics Stock
Based on 2 analysts
100.00%
Buy
0.00%
Hold
0.00%
Sell
Based on 2 analysts, 100% of analysts recommend a 'BUY' rating for Chemomab Therapeutics. Average target price of $5
Chemomab Therapeutics Share Price Target
Get share price movements and forecasts by analysts on Chemomab Therapeutics.
What analysts predicted
58.2%UPSIDE
Target Price
$5
Current Price
$2.09
Analyzed by
2 Analysts
Target
$5.00
Chemomab Therapeutics target price $5, a slight upside of 58.2% compared to current price of $2.09. According to 2 analysts rating.
Indian Investors' Interest in Chemomab Therapeutics Stock
Search interest for Chemomab Therapeutics Stock has decreased by -19% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Chemomab Therapeutics Quarterly Profit & Loss
All numbers in Millions USD
Chemomab Therapeutics Annual Profit & Loss
All numbers in Millions USD
Chemomab Therapeutics Quarterly Cash Flow
All numbers in Millions USD
Chemomab Therapeutics Annual Cash Flow
All numbers in Millions USD
Insights on Chemomab Therapeutics
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTPrice Rise
In the last 7 days, CMMB stock has moved up by 10.0%
NO EFFECTAgainst Peers
In the last 1 year, Revolution Medicines, Inc. Common Stock has given 493.6% return, outperforming this stock by 536.7%
- NO EFFECT
Against Peers
In the last 3 years, Revolution Medicines, Inc. Common Stock has given 624.7% return, outperforming this stock by 676.8%
About Chemomab Therapeutics
| Organisation | Chemomab Therapeutics |
| Headquarters | Building C, Tel Aviv-Yafo, Israel, 6158101 |
| Industry | Biotechnology |
| CEO | Dr. Adi Mor George Ph.D. |
| E-voting on shares | Click here to vote |
Key Management of Chemomab Therapeutics
Name | Title |
|---|---|
Mr. John Lawler | Chief Development Officer |
Ms. Barbara L. Lindheim | Consulting Vice President of Investor & Public Relations, Strategic Communications |
Dr. David M. Weiner M.B.A., M.D. | Interim Chief Medical Officer |
Dr. Adi Mor George Ph.D. | Co-Founder, Chief Scientific Officer, CEO & Executive Director |
Ms. Sigal Fattal CPA, M.B.A. | Chief Financial Officer |
FAQs
What is Chemomab Therapeutics share price today?
Chemomab Therapeutics share price today is $2.09 as on at the close of the market. Chemomab Therapeutics share today touched a day high of $2.10 and a low of $1.88.
What is the 52 week high and 52 week low for Chemomab Therapeutics share?
Chemomab Therapeutics share touched a 52 week high of $4.12 on and a 52 week low of $1.35 on . Chemomab Therapeutics stock price today i.e. is closed at $2.09,which is 49.27% down from its 52 week high and 54.81% up from its 52 week low.
What is Chemomab Therapeutics's market capitalisation today?
Chemomab Therapeutics market capitalisation is $0.00T as on .
How to invest in Chemomab Therapeutics Stock (CMMB) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Chemomab Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Chemomab Therapeutics Shares that will get you 0.7177 shares as per Chemomab Therapeutics share price of $2.09 per share as on August 20, 2026 at 8:46 am IST.
What is the minimum amount required to buy Chemomab Therapeutics Stock (CMMB) from India?
Indian investors can start investing in Chemomab Therapeutics (CMMB) shares with as little as ₹95.743 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹957.43 in Chemomab Therapeutics stock (as per the Rupee-Dollar exchange rate as on ).
Based on Chemomab Therapeutics share’s latest price of $2.09 as on August 20, 2026 at 8:46 am IST, you will get 4.7847 shares of Chemomab Therapeutics. Learn more about
fractional shares .
What are the returns that Chemomab Therapeutics has given to Indian investors in the last 5 years?
Chemomab Therapeutics stock has given -96.4% share price returns and 28.54% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?